3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myeloid, Acute
3
Sarcoma
2
Rhabdomyosarcoma
2
Myelodysplastic Syndromes
2
Leukemia, Biphenotypic, Acute
2
Ganglioneuroblastoma
2
Sarcoma, Myeloid
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pleuropulmonary blastoma
1
PRETEXT I Hepatoblastoma
1
Neuroblastoma
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Malignant mesenchymal tumor
1
Lymphoma, Large B-Cell, Diffuse
1
Localized Extraskeletal Ewing Sarcoma
1
Leukemia
1
Heart Failure
1
Drug-Related Side Effects and Adverse Reactions
1
Dendritic Cell Sarcoma, Interdigitating
1
Degradation of Top2b and Top2a in Human by Dexrazoxane
1
Cardiotoxicity
1
Burkitt Lymphoma
1
Blast Crisis
1
Interventions
Doxorubicin
6
Specimen Handling
5
Radiotherapy
3
Radiation
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Gemcitabine
3
Biopsy
3
pembrolizumab
2
liposomal doxorubicin
2
eribulin
2
Ifosfamide
2
toripalimab
1
talimogene laherparepvec
1
rucaparib
1
ribociclib
1
regorafenib
1
peposertib
1
pazopanib
1
olaratumab
1
olaparib
1
lenvatinib
1
futibatinib
1
durvalumab
1
dinutuximab
1
cemiplimab
1
cediranib
1
cabozantinib
1
avelumab
1
anlotinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leiomyosarcoma
×
Dexrazoxane
×
1 year
×
Clear all
No trials found.